{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:17:02Z","timestamp":1771665422550,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23MH095679"],"award-info":[{"award-number":["K23MH095679"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s13365-016-0466-z","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T18:12:37Z","timestamp":1468260757000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals"],"prefix":"10.1007","volume":"23","author":[{"given":"Albert M.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark M.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Loring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeth","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Easley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Tyor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0163-4453(87)93147-1","volume":"15","author":"RJ Abbott","year":"1987","unstructured":"Abbott RJ, Bolderson I, Gruer PJ (1987) Assessment of an immunoassay for interferon-alpha in cerebrospinal fluid as a diagnostic aid in infections of the central nervous system. J Infect 15:153\u2013160","journal-title":"J Infect"},{"key":"466_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789\u20131799","journal-title":"Neurology"},{"key":"466_CR3","doi-asserted-by":"crossref","unstructured":"Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK, Hnrc Group (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307\u2013319","DOI":"10.1080\/13803390490510031"},{"key":"466_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12883-015-0298-0","volume":"15","author":"LA Cysique","year":"2015","unstructured":"Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ (2015) APOE epsilon4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study. BMC Neurol 15:51","journal-title":"BMC Neurol"},{"key":"466_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2012.01.001","volume":"23","author":"C Fritz-French","year":"2012","unstructured":"Fritz-French C, Tyor W (2012) Interferon-alpha (IFNalpha) neurotoxicity. Cytokine Growth Factor Rev 23:7\u201314","journal-title":"Cytokine Growth Factor Rev"},{"key":"466_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1089\/jir.2013.0072","volume":"34","author":"C Fritz-French","year":"2014","unstructured":"Fritz-French C, Shawahna R, Ward JE, Maroun LE, Tyor WR (2014) The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model. J Interf Cytokine Res 34:510\u2013517","journal-title":"J Interf Cytokine Res"},{"key":"466_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-6405-7-15","volume":"7","author":"L Hagberg","year":"2010","unstructured":"Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 7:15","journal-title":"AIDS Res Ther"},{"key":"466_CR8","doi-asserted-by":"publisher","first-page":"e56527","DOI":"10.1371\/journal.pone.0056527","volume":"8","author":"GA Hardy","year":"2013","unstructured":"Hardy GA, Sieg S, Rodriguez B, Anthony D, Asaad R, Jiang W, Mudd J, Schacker T, Funderburg NT, Pilch-Cooper HA, Debernardo R, Rabin RL, Lederman MM, Harding CV (2013) Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS One 8:e56527","journal-title":"PLoS One"},{"key":"466_CR9","unstructured":"Heaton RK, Miller SW, Taylor MJ, Grant I (2004) Revised Comprehensive norms for an expanded Halstead- Reitan Battery: Demographically adjusted neuropsycho-logical norms for African American and Caucasian adults scoring program."},{"key":"466_CR10","doi-asserted-by":"crossref","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, RJ E, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, OR V, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087\u20132096","DOI":"10.1212\/WNL.0b013e318200d727"},{"key":"466_CR11","first-page":"97","volume":"36","author":"S Kakumu","year":"1989","unstructured":"Kakumu S, Fuji A, Yoshioka K, Tahara H (1989) Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis. Hepato-Gastroenterology 36:97\u2013102","journal-title":"Hepato-Gastroenterology"},{"key":"466_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/jir.2014.0105","volume":"35","author":"CF Kessing","year":"2015","unstructured":"Kessing CF, Tyor WR (2015) Interferon-alpha induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor. J Interf Cytokine Res 35:317\u2013324","journal-title":"J Interf Cytokine Res"},{"key":"466_CR13","doi-asserted-by":"crossref","unstructured":"Marcotte TD, Deutsch R, Michael BD, Franklin D, Cookson DR, Bharti AR, Grant I, Letendre SL, for the CHARTER group (2013). A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol.","DOI":"10.1007\/s11481-013-9504-2"},{"key":"466_CR14","doi-asserted-by":"publisher","first-page":"e116081","DOI":"10.1371\/journal.pone.0116081","volume":"9","author":"J Peterson","year":"2014","unstructured":"Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW (2014) Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 9:e116081","journal-title":"PLoS One"},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11481-013-9442-z","volume":"8","author":"MC Potter","year":"2013","unstructured":"Potter MC, Figuera-Losada M, Rojas C, Slusher BS (2013) Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J NeuroImmune Pharmacol 8:594\u2013607","journal-title":"J NeuroImmune Pharmacol"},{"key":"466_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.WNF.0000220824.57769.E5","volume":"29","author":"LC Quarantini","year":"2006","unstructured":"Quarantini LC, Miranda-Scippa A, Schinoni MI, Sampaio AS, Santos-Jesus R, Bressan RA, Tatsch F, de Oliveira I, Parana R (2006) Effect of amantadine on depressive symptoms in chronic hepatitis C patients treated with pegylated interferon: a randomized, controlled pilot study. Clin Neuropharmacol 29:138\u2013143","journal-title":"Clin Neuropharmacol"},{"key":"466_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1006\/brbi.1995.1034","volume":"9","author":"MB Rho","year":"1995","unstructured":"Rho MB, Wesselingh S, Glass JD, McArthur JC, Choi S, Griffin J, Tyor WR (1995) A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav Immun 9:366\u2013377","journal-title":"Brain Behav Immun"},{"key":"466_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-0034-1372339","volume":"34","author":"K Robertson","year":"2014","unstructured":"Robertson K, Yosief S (2014) Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders. Semin Neurol 34:21\u201326","journal-title":"Semin Neurol"},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","volume":"21","author":"KR Robertson","year":"2007","unstructured":"Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915\u20131921","journal-title":"AIDS"},{"key":"466_CR20","doi-asserted-by":"crossref","unstructured":"Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, Paul R, Robertson K, Jarocki B, Scarsi K, Coombs RW, Zink MC, Nath A, Smith E, Ellis RJ, Singer E, Weihe J, McCarthy S, Hosey L, Clifford DB, ACTG A5235 team (2011) Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology 77:1135\u20131142","DOI":"10.1212\/WNL.0b013e31822f0412"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1523\/JNEUROSCI.5595-08.2009","volume":"29","author":"AR Sas","year":"2009","unstructured":"Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR (2009) Interferon-alpha causes neuronal dysfunction in encephalitis. J Neurosci 29:3948\u20133955","journal-title":"J Neurosci"},{"key":"466_CR22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","volume":"83","author":"T Skillback","year":"2014","unstructured":"Skillback T, Farahmand B, Bartlett JW, Rosen C, Mattsson N, Nagga K, Kilander L, Religa D, Wimo A, Winblad B, Rosengren L, Schott JM, Blennow K, Eriksdotter M, Zetterberg H (2014) CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology 83:1945\u20131953","journal-title":"Neurology"},{"key":"466_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/088922203322280856","volume":"19","author":"V Tozzi","year":"2003","unstructured":"Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW (2003) Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retrovir 19:643\u2013652","journal-title":"AIDS Res Hum Retrovir"},{"key":"466_CR24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1212\/WNL.0b013e3181f4d5bb","volume":"75","author":"P Vivithanaporn","year":"2010","unstructured":"Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C (2010) Neurologic disease burden in treated HIV\/AIDS predicts survival: a population-based study. Neurology 75:1150\u20131158","journal-title":"Neurology"},{"key":"466_CR25","doi-asserted-by":"crossref","unstructured":"Zetterberg H, Skillback T, Mattsson N, Trojanowski JQ, Portelius E, Shaw LM, Weiner MW, Blennow K, Alzheimer's Disease Neuroimaging I (2016) Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol 73:60\u201367","DOI":"10.1001\/jamaneurol.2015.3037"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-016-0466-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-016-0466-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-016-0466-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-016-0466-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T23:33:22Z","timestamp":1656804802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-016-0466-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s13365-016-0466-z","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]},"assertion":[{"value":"15 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Emory Medical Care Foundation.NIH K23MH095679.NIH P30 AI050409 (Emory Center for AIDS Research).The Knut and Alice Wallenberg Foundation.The Torsten S\u00f6derberg Foundation.The Swedish Research Council.The European Research Council.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No financial disclosures to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}